Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P06889 (
Mol
)
630,302
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Although circulating
ghrelin
levels correlate inversely with adiposity at baseline, little is known about the effect of percent visceral adipose tissue value (PVATV) on
ghrelin
expression and secretion in response to fasting. Our study demonstrated that
ghrelin
increased with 24-h fasting in rats with the lowest PVATV (less than 6%), after 3 days in rats with intermediate PVATV (6-9%) and 5 days in rats with the highest PVATV (greater than 9%). Ghrelin mRNA in the stomach was increased after 3 days in low-PVATV (5.8+/-0.9%) rats but not in high-PVATV (14+/-1.6%) rats. Therefore, both
ghrelin
secretion and mRNA were delayed in response to fasting in rats with increased visceral fat. In rats matched for PVATV, but with different body weights, the fasting induced similar levels of increased
ghrelin
while in rats with different PVATV
ghrelin
secretion was different in response to fasting, even when body weights were matched in two groups. These data suggested that the initial PVATV, not lean mass, was related to the pattern of plasma
ghrelin
in response to fasting in rats.
J
Mol
Endocrinol 2009 Jan
PMID:Influence of visceral adiposity on ghrelin secretion and expression in rats during fasting. 1897 28
We searched for evidence of the hormone
ghrelin
in the stomach of a juvenile, marine teleost, the summer flounder. Using antiserum against the conserved core of the
ghrelin
peptide, immunoreactivity was observed in the simple, branching epithelium that comprises the gastric glands. The immunoreaction was especially strong in the glandular epithelium located deep in the tissue. Next, we assessed a possible connection between
ghrelin
and the hypothalamic-pituitary-interrenal axis through a series of three injection experiments in which acylated or non-acylated (des-acyl)
ghrelin
was injected into the peritoneum of summer flounder (Paralichthys dentatus). A significant increase in plasma cortisol relative to saline-injected controls was observed for the acylated form at a dose of 1000 ng g(-1) of body mass in one of the experiments. In another, there was a trend for des-acyl
ghrelin
at 1000 ng g(-1) of body mass to increase plasma cortisol. Taken together, this study provides evidence that gastric glands in the stomach of summer flounder are a site of
ghrelin
production and that peripherally administered
ghrelin
can stimulate the cortisol axis in a teleost.
Comp Biochem Physiol A
Mol
Integr Physiol 2009 Feb
PMID:Ghrelin in the summer flounder: immunolocalization to the gastric glands and action on plasma cortisol levels. 1902 92
Ghrelin regulates appetite in mammals and can stimulate growth hormone (GH) release from the pituitary. In rats and humans,
ghrelin
cells appear in the stomach during late fetal life. Nevertheless, the role of
ghrelin
in early mammalian development is not well understood. Marsupials deliver highly altricial young that weigh less than 1g so they must feed and digest milk at a comparatively immature stage of development. Since they complete their growth and differentiation while in the pouch, they are accessible models in which to determine the time course of
ghrelin
production during development. We examined the distribution of gastric
ghrelin
cells, plasma
ghrelin
concentrations and pituitary expression of the ghrelin receptor (ghsr-1alpha) and GH in the tammar wallaby, Macropus eugenii. There were
ghrelin
immunopositive cells in the developing mesenchyme of the stomach from day 10 post partum (pp) to day 150pp. Subsequently
ghrelin
protein in the fore-stomach declined and was absent by day 250pp but remained in the gastric cells of the hind-stomach. Ghrelin was detected in the developing pancreas from day 10pp but was absent by day 150pp and in the adult. Pituitary ghsr-1alpha expression and plasma concentrations of
ghrelin
increased significantly up to day 70-120pp while GH expression was also elevated, declining with GH to reach adult levels by day 180pp. These results demonstrate an early onset of gastric
ghrelin
expression in the tammar in concert with a functional stomach at a relatively earlier stage than that of developmentally more mature eutherian young.
Mol
Cell Endocrinol 2009 Feb 27
PMID:Early onset of ghrelin production in a marsupial. 1902 14
Ghrelin and obestatin are two peptide hormones with opposing roles in the control of appetite: orexigenic and anorexigenic, respectively. Loss of appetite is a common, serious complication of many forms of malignancy. The goals of this study were to investigate: (i) whether there are differences in
ghrelin
and obestatin peptide expression in thyroid tissues from a series of papillary carcinoma cases and normal controls, and (ii) whether there are correlations between tissue
ghrelin
and obestatin levels in series of papillary carcinoma cases and normal controls. Immunohistochemical analysis showed that in sections of benign human thyroid tissue, anti-
ghrelin
antibody reacted with intense staining in colloid-filled follicles. In benign thyroid tissues, colloids displayed plentiful dispersion in comparison with papillary microcarcinomas, whereas colloids in malignant thyroid tissues were uncommon. We found markedly lower tissue
ghrelin
levels in thyroid tissue of patients with papillary carcinomas, compared with normal thyroid tissues (P = 0.001). Immunohistochemical analysis also showed that obestatin in papillary carcinoma stained positively to various degrees. Obestatin tissue levels in papillary carcinomas tended to be slightly higher than those in normal thyroid tissue, but this was not statistically significant (P = 0.29). We also report that thyroid tissue of patients with Hashimoto's thyroiditis produced
ghrelin
and obestatin at similar levels as in normal thyroid tissue, even though colloid in Hashimoto's disease is scarce. We conclude that depressed expression of
ghrelin
, but not obestatin, is specific to papillary carcinoma, and this difference might constitute a diagnostic tool to differentiate papillary carcinoma from normal thyroid tissue. We currently do not know how these peptides are regulated and what factors are involved in papillary carcinoma, which inhibit the expression of
ghrelin
but not obestatin. This issue warrants further studies.
Mol
Cell Biochem 2009 Mar
PMID:Expression of obestatin and ghrelin in papillary thyroid carcinoma. 1903 50
Ghrelin is an endogenous ligand for the growth hormone secretagogue receptor (GHS-R) acting to stimulate growth hormone release. In the previous study, we have observed the neuroprotective effects of
ghrelin
on dopaminergic neurons in vivo in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine -treated Parkinson's disease mice. In order to illustrate the underlying mechanisms, in the present study, we conducted our experiment in vitro in 1-methyl-4-phenylpyridinium (MPP(+))-treated MES23.5 cells that could express GHS-R1a. Ten- to 1,000-micromol/L MPP(+) treatment caused decreased cell viability, with increased lactate dehydrogenase leakage. A 200-micromol/L MPP(+) treatment was chosen to do the further experiments. MES23.5 cells treated with 200 micromol/L MPP(+) showed decreased mitochondrial transmembrane potential, an elevated level of reactive oxidative species production and activation of caspase-3. Additionally, these cells also showed apoptotic morphological changes. Pretreatment with different doses of
ghrelin
(10(-12)-10(-7) mol/L) could abolish the MPP(+)-induced apoptotic changes in a dose-dependent manner. These results suggested that
ghrelin
could antagonize MPP(+)-induced apoptosis in MES23.5 cells. The protective effects of
ghrelin
involved the restoration of mitochondria function.
J
Mol
Neurosci 2009 Feb
PMID:Ghrelin antagonized 1-methyl-4-phenylpyridinium (MPP(+))-induced apoptosis in MES23.5 cells. 1905 22
In vertebrates including fish, food intake regulation involves intricate networks of hormones produced by both brain and peripheral tissues. Under optimum conditions, nutritional intake is adequate for basal metabolic needs, growth, development, reproduction, and deposition of energy stores. As fish represent a very diverse group, different fish species live in very different environments and are exposed to variations in a wide range of factors, including not only internal factors, such as nutritional/metabolic status and reproductive events but also environmental factors, such as temperature and photoperiod. These physiological responses often include changes in appetite that might occur through modulations of the gene expression and action of feeding-regulating hormones. Despite recent advances, our current understanding of the regulation of feeding in fish is still limited and based primarily on studies involving a few fish species. This review will give a brief overview of our current knowledge of the regulation of feeding by three central (NPY, OX and CART) and two peripheral (
ghrelin
and GRP) appetite-related factors in a freshwater species, the goldfish (Carassius auratus) and two marine species, cod (Gadus morhua) and winter flounder (Pleuronectes americanus).
Comp Biochem Physiol A
Mol
Integr Physiol 2009 May
PMID:Aspects of the hormonal regulation of appetite in fish with emphasis on goldfish, Atlantic cod and winter flounder: notes on actions and responses to nutritional, environmental and reproductive changes. 1908 89
Ghrelin is a 28-amino acid peptide secreted mainly by the stomach. Acyl-
ghrelin
, which binds to and activates the growth hormone secretagogue receptor type 1a (GHS-R1a), is considered to be the active form for its orexigenic effects. It has been demonstrated that peripheral administration of
ghrelin
stimulates food intake and adiposity in rodents and humans. Accordingly, different approaches to antagonize
ghrelin
/GHS-R1a signaling have been pursued for the treatment of obesity. In the present study, we generated and characterized high-affinity anti-acyl
ghrelin
-specific monoclonal antibodies (mAbs). In vitro, the lead mAb (33A) displayed specific binding to acyl-
ghrelin
, with an estimated K(d) value < 100 pM. In recombinant receptor cell-based assays, 33A dose-dependently inhibited the
ghrelin
-mediated calcium signal, with an IC(50) of approximately 3.5 nM. In vivo,
ghrelin
dose-dependently stimulated food intake in mice, and this effect was fully blocked by a single injection of 33A. In a 4-week chronic study, 33A was shown to effectively bind to endogenous acyl-
ghrelin
; however, long-term administration of 33A did not affect food intake or body weight gain in a mouse model of diet-induced obesity. Our results indicate that peripheral neutralization of
ghrelin
can suppress appetite stimulated by a transient surge in
ghrelin
levels. The lack of long-term effects on body weight control by 33A suggests that compensatory mechanisms may contribute to the regulation of energy balance.
Mol
Pharmacol 2009 Apr
PMID:An acyl-ghrelin-specific neutralizing antibody inhibits the acute ghrelin-mediated orexigenic effects in mice. 1912 26
GH secretagogue receptor (ghrelin receptor, GHSR) is known to be involved in the control of GH release by mediating the strong stimulatory effect of the endogenous ligand,
ghrelin
, on GH secretion. Associations between the GHSR gene polymorphism and the growth traits were revealed in Nanyang cattle. The mutations at nt456(G > A) and nt667(C > T) were complete linkage and located in exon 1 of the coding region of the GHSR gene. Least squares analysis revealed a significant statistical effect (P < 0.05) of the GHSR gene different genotypes on body weight and average daily gain at 6 months of age in Nanyang cattle. Individuals with GHSR-MM genotype showed higher body weight and average daily gain than individuals with GHSR-MN genotype.
Mol
Biol Rep 2009 Nov
PMID:Associations of polymorphism within the GHSR gene with growth traits in Nanyang cattle. 1914 73
Members of the MBOAT family of multispanning transmembrane enzymes catalyze the acylation of important secreted signalling proteins of the Hedgehog, Wg/Wnt and
ghrelin
families. Acylation of these substrates occurs during transport through the secretory pathway and plays key roles in their biological activity and spread from producing cells, contributing to the formation of appropriate extracellular concentration gradients. Characterization of these enzymes could lead to their identification as therapeutic targets for diverse human diseases such as cancers, obesity and diabetes.
Mol
Membr Biol 2009 Jan
PMID:Acyltransferases for secreted signalling proteins (Review). 1916 35
Nesfatin-1 and
ghrelin
are the two recently discovered peptide hormones involved in the control of appetite. Besides its main appetite-control function,
ghrelin
also has anticonvulsant effects, while nesfatin-1 causes depolarization in the paraventricular nucleus (PVN). The aims of this study, therefore, were to investigate: (i) whether there are differences in the concentrations of nesfatin-1 and
ghrelin
in saliva and serum samples between eplilepsy patients and normal controls and (ii) whether salivary glands produce nesfatin-1. The study included a total of 73 subjects: 8 patients who were newly diagnosed with primary generalized seizures and had recently started antiepileptic drug therapy; 21 who had primary generalized seizures and were continuing with established antiepileptic drug therapy; 24 who had partial seizures (simple: n = 12 or complex: n = 12) and were continuing with established antiepileptic drug therapy; and 20 controls. Salivary gland tissue samples were analyzed for nesfatin-1 expression by immunochemistry and ELISA. Saliva and serum
ghrelin
levels were measured by ELISA and RIA, and nesfatin-1 levels by ELISA. Nesfatin-1 immunoreactivity was detected in the striated and interlobular parts of the salivary glands and the ducts. The nesfatin-1 level in the brain was around 12 times higher than in the salivary gland. Before antiepileptic treatment, both saliva and serum nesfatin-1 levels were around 160-fold higher in patients who are newly diagnosed with primary generalized epilepsy (PGE) than in controls; these levels decreased with treatment but remained about 10 times higher than the control values. Saliva and serum nesfatin-1 levels from patients with PGE and partial epilepsies who were continuing antiepileptic drugs were also 10-fold higher than control values. Serum and saliva
ghrelin
levels were significantly (twofold) lower in epileptic patients before treatment than in controls; they recovered somewhat with treatment but remained below the control values. These results suggest that the low
ghrelin
and especially the dramatically elevated nesfatin-1 levels might contribute to the pathophyisology of epilepsy. Therefore, serum and saliva
ghrelin
and especially the remarkably increased nesfatin-1 might be candidate biomarkers for the diagnosis of epilepsy and for monitoring the response to anti-epileptic treatment.
Mol
Cell Biochem 2009 Aug
PMID:Nesfatin-1 and ghrelin levels in serum and saliva of epileptic patients: hormonal changes can have a major effect on seizure disorders. 1926 95
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>